Pure Global

AGAPPE Albumin Mispa CCXL, CXLpro, CX4 - Indonesia BPOM Medical Device Registration

AGAPPE Albumin Mispa CCXL, CXLpro, CX4 is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101220639. The device is manufactured by AGAPPE DIAGNOSTICS SWITZERLAND GMBH. from Switzerland, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is MULTIMEDILAB KARYAMANDIRI.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
AGAPPE Albumin Mispa CCXL, CXLpro, CX4
Analysis ID: AKL 20101220639

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

Switzerland

Authorized Representative

MULTIMEDILAB KARYAMANDIRI

AR Address

GP plaza lantai 3 unit 6, jalan Gelora II No. 01

Registration Date

Oct 21, 2024

Expiry Date

Feb 07, 2027

Product Type

Clinical Chemistry Test System

Albumin test system (kit & cair)

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing